• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, September 11, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Study finds failure to sustain reductions in carcinogens in cigarettes

Bioengineer by Bioengineer
June 8, 2017
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Waterloo, Ontario: Tobacco-specific nitrosamines (TSNAs) are potent carcinogens formed predominantly during the cigarette manufacturing process. Despite initial success lowering TSNA levels in cigarettes sold in Canada, following subsidies by the Ontario government to manufacturers in 2000, a study published today in the journal Nicotine & Tobacco Research has found that the decrease in TSNAs have not been sustained.

The authors reviewed TSNA levels in unburned tobacco and in tobacco smoke from cigarettes produced by manufacturers that constitute 90% of Canada's cigarette market. Following initial reductions, TSNA levels in cigarettes sold in Canada consistently increased after 2007. By 2012, the levels were 2 to 40 times higher than those observed in 2007.

Though TSNA levels at the end of the study period were still below those before government subsidies, the increases raise several important issues. "Overall, the findings indicate alarming increases in the TSNA levels of cigarettes sold in Canada," says co-author Dr. David Hammond, researcher at the School of Public Health & Health Systems at the University of Waterloo. While the increases in TSNAs should not be interpreted as a direct increase in health risk, Hammond says "manufacturers bear a responsibility to minimize consumer exposure to potent carcinogens to the fullest extent possible. The failure to sustain these reductions signifies a lack of commitment towards harm reduction."

###

The paper "Trends over time in tobacco-specific nitrosamines (TSNAs) in whole tobacco and smoke emissions from cigarettes sold in Canada" is available at: https://academic.oup.com/ntr/article/3861560/Trends-Over-Time-in-Tobacco-Specific-Nitrosamines?searchresult=1

Direct correspondence to: Dr. David Hammond ([email protected])

To request a copy of the study, please contact:

Daniel Luzer ([email protected] or 212-743-6113)

Sharing on social media? Find Oxford Journals online at @OxfordJournals

Media Contact

Daniel Luzer
[email protected]

http://global.oup.com/academic/;jsessionid=13378C4

https://academic.oup.com/ntr/article/3861560/Trends-Over-Time-in-Tobacco-Specific-Nitrosamines?searchresult=1

Related Journal Article

http://dx.doi.org/10.1093/ntr/ntx103

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Poly-L-Histidine-Coated Nanoparticles for Targeted Doxorubicin Delivery

September 11, 2025

Barriers to Video Visits for Non-English Patients

September 11, 2025

Smart ROS Nanoplatform Boosts Targeted Cancer Therapy

September 11, 2025

Creating AI Companions for Caregiver Role Transitions

September 11, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    152 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    64 shares
    Share 26 Tweet 16
  • First Confirmed Human Mpox Clade Ib Case China

    56 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Poly-L-Histidine-Coated Nanoparticles for Targeted Doxorubicin Delivery

Revolutionary Ion Exchange Membranes for Arsenic Removal

PATZ1: Key Player in Tumorigenesis and Metabolism

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.